These results suggest that individuals with the IL-1RN rs419598, or BCL2 rs2279115 polymorphisms showed a significant reduction in HNSCC risk progression, whereas those with the PIGR rs291102 dominance model had increased HNSCC risk. This evidence concerns the gene BCL2 and head and neck squamous cell carcinoma.